PRIMARY BILIARY CHOLANGITIS WITH SJOGREN’S SYNDROME: A CASE REPORT

Thị Minh Tâm Mai1, , Thị Quỳnh Anh Hoàng1, Thu Phương Phạm1, Khắc Khiêm Phạm1, Trường Khanh Vũ1
1 Bệnh viện Đa khoa Tâm Anh Hà Nội

Main Article Content

Abstract

Primary biliary cholangitis is a chronic autoimmune liver disease and is relatively rare. It is caused by the destruction of the small intrahepatic bile ducts, leading to cholestasis, inflammation, and eventually cirrhosis. The disease is characterized by the presence of anti-mitochondrial antibodies (AMA), is associated with autoimmune mechanisms, and is often accompanied by other autoimmune disorders. Sjögren’s syndrome is commonly observed in patients with primary biliary cholangitis, with a prevalence ranging from 7-34 %, presenting with symptoms such as dry eyes, salivary gland swelling, joint involvement, myalgia, muscle weakness, pruritus, cutaneous vasculitis, Raynaud’s phenomenon, respiratory involvement, and neurological manifestations. We describe the case of a 46-year-old female patient who had been diagnosed with and treated for primary biliary cholangitis for many years, with positive anti-mitochondrial antibodies, in association with Sjögren’s syndrome. Her clinical manifestations included dry mouth and cold-induced pain in the second fingers of both hands, along with positive antinuclear antibodies: SSA, Ro-52, gp210, and Mi-2β antibodies. The patient’s disease was controlled with a combination of ursodeoxycholic acid, fibrates, and comprehensive care.

Article Details

References

1. González-Huezo MS, Delgado-Ayala LY, Osorio-Núñez AL, Meléndez-Mercado C. Autoimmune associations in a Mexican cohort with primary biliary cholangitis. Rev Gastroenterol Mex (Engl Ed). 2019;84(2):130-135. doi: 10.1016/j.rgmx.2018.03.008.
2. Hachulla E, David Launay, Vincent Sobanski, Sébastien Sanges, Emmanuel Ledoult. Quand penser à un syndrome de Sjögren primitif ? HAL Id: hal-05243732 https://hal.science/hal-05243732v1 Submitted on 1 Oct 2025
3. Lindor KD, Bowlus CL, Boyer J, Levy C, Mayo M. Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases. Hepatology. 2019;69(1):394-419. doi:10.1002/hep.30145
4. Mouelhi L, Ayadi S, Sfar I, Houissa F, Eljeri K, Khedher S, et al. Le syndrome de Gougerot-Sjögren au cours de la cholangite biliaire primitive. Rev Med Interne. 2016;37(Suppl 1).
5. Shiboski CH, Shiboski SC, Seror R, et al: 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren’s syndrome: A consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol 69(1):35–45, 2017. doi: 10.1002/art.39859
6. Soret PA, Chazouillères O, Corpechot C. Cholangite biliaire primitive. Rev Prat. 2021;71(8):885-891.
7. Souiai H, Ben Salah R, Derbel A, Mouna S, Faten F, Sameh M, et al. La cholangite biliaire primitive associée aux maladies systémiques. Rev Med Interne. 2024;45(Suppl 1).
8. Zhang H, Li S, Feng Y, Zhang Q, Xie B. Efficacy of fibrates in the treatment of primary biliary cholangitis: a meta-analysis. Clin Exp Med. 2023;23(5):1741-1749. doi:10.1007/s10238-022-00904-2.